Delivery Order SPE2DB20D7059-SPE2DB25FQDZ5
Award Date
4/11/25
Potential Completion Date
4/14/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OFLOXACIN 0.3% EAR DROPS 5ML. The $5,469.25 firm fixed-price delivery order has an ultimate completion date of January 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,594.16 firm-fixed-price delivery order is for OFLOXACIN 0.3% EAR DROPS 10ML, with a completion date of September 13, 2022. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $3,793.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of OFLOXACIN 0.3% EAR DROPS 5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of February 18, 2025. No set-aside designation was used for this award. In addition to this specific delivery order, AmerisourceBergen holds a significant Indefinite...
This federal contract award, SPE2DB20D3103|SPE2DB23FN3E3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of OFLOXACIN 0.3% EAR DROPS 5ML. The $2,976.65 firm fixed-price delivery order has a completion date of May 9, 2023 and is not designated as a set-aside. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), has an extensive history of federal contract...
This federal contract award is for the delivery of OFLOXACIN 0.3% EAR DROPS 10ML to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,945.69, is a Firm Fixed Price Delivery Order with an ultimate completion date of August 16, 2021. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award to Amerisourcebergen Drug Corp is for the delivery of OFLOXACIN 0.3% EAR DROPS 10ML, with a ceiling value of $1,933.30. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OFLOXACIN 0.3% EAR DROPS 5ML. The contract has a firm fixed price of $2,630.69 and a performance period ending on April 10, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of OFLOXACIN 0.3% EAR DROPS 10ML, a pharmaceutical product, with a ceiling value of $3,486.18. The contract was awarded on September 27, 2022, with a completion date of September 28, 2022, and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation is for the delivery of Ofloxacin 0.3% ear drops. The $3,047.55 firm fixed price delivery order contract has an ultimate completion date of June 10, 2025. Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, is the prime contractor for this delivery order, which is not designated as a set-aside. The contract is part of a larger $999,999,999.00 Indefinite Delivery Contract...
This federal contract award is for the delivery of 4566353556 - OFLOXACIN 0.3% EAR DROPS 10ML, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,494.05 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA) on November 6, 2024, with a completion date of November 7, 2024. The contract is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp,...